AMZN
Amazon.com, Inc.
AMZN has lower modeled downside risk, despite its lower overall score.
RCKY
Rocky Brands, Inc.
RCKY has a slight edge over AMZN overall, supported by stronger fundamentals.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
RCKY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Healthy |
RCKY's revenue, profitability, cash flow and balance sheet are all currently healthy.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over RCKY in the historical PE scenario, which offers more potential upside but is not a forecast.
RCKY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $46.61 | -9.9% |
| Current | 11x | $51.71 | — |
| Fair | 13x | $58.73 | +14% |
| Forward | 13x | $51.71 | — |
| Expensive | 17x | $75.66 | +46% |
Historical ranges are pointers, not guarantees.
RCKY's PE is in its cheap range at 11x. On analysts' estimates for next year's earnings, today's price would be 13x, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
RCKY Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for RCKY, with profitability improving.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over RCKY on earnings, with stronger typical year-over-year growth.
RCKY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.09 | -10% |
| Q3 2026 | $4.55 | +65% |
| Q2 2026 | $3.82 | +53% |
| Q1 2026 | $2.47 | +34% |
| Q4 2025 | $2.96 | +95% |
| Q3 2025 | $2.75 | +55% |
| Q2 2025 | $2.49 | +25% |
| Q1 2025 | $1.84 | +2.2% |
| Q4 2024 | $1.52 | +7.8% |
RCKY's earnings per share have climbed steadily: $4.55 over the past year, up 65% from the year before, and higher year over year for 11 quarters in a row.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over RCKY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over RCKY on profitability, with a higher operating margin.
RCKY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $138.8M | +13% |
| Q2 2026 | $118.4M | +12% |
| Q1 2026 | $124.4M | +9.1% |
| Q4 2025 | $139.7M | +9.1% |
| Q3 2025 | $122.5M | +7% |
| Q2 2025 | $105.6M | +7.5% |
| Q1 2025 | $114.1M | +1% |
| Q4 2024 | $128.1M | +1.7% |
RCKY's revenue has grown year over year for eight quarters in a row: $139M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +3.5 points |
| Q2 2026 | 17% | +9.9 points |
| Q1 2026 | 2.9% | -4.7 points |
| Q4 2025 | 6.9% | +0.2 points |
| Q3 2025 | 9.6% | +0.8 points |
| Q2 2025 | 6.8% | +2.2 points |
| Q1 2025 | 7.6% | +0.6 points |
| Q4 2024 | 6.6% | -5.1 points |
RCKY's operating margin was 13% last quarter, up 3.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
RCKY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3M | +$11.4M |
| Q2 2026 | $4.1M | +$6.5M |
| Q1 2026 | $744K | +41% |
| Q4 2025 | $16.7M | -27% |
| Q3 2025 | -$5.2M | -249% |
| Q2 2025 | -$2.4M | -151% |
| Q1 2025 | $529K | -97% |
| Q4 2024 | $22.9M | -45% |
RCKY has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over RCKY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
RCKY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +21K shares |
| 1 year | +1% | +76K shares |
| 3 years | +3.3% | +244K shares |
| 5 years | +3.4% | +249K shares |
| Available history | +2.4% | +180K shares |
RCKY has 8M diluted shares, up 1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $2M |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $201,000 |
| Q4 2021 | — |
RCKY spent $2M buying back its own shares over the past year.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over RCKY on leverage, with a lower net debt burden relative to earnings.
RCKY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q2 2026 | 2.2x | Moderate |
| Q1 2026 | 2.9x | Moderate |
| Q4 2025 | 2.6x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 3.0x | Elevated |
| Q4 2024 | 3.0x | Elevated |
RCKY's net debt is about 1.9 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
RCKY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.5 | Neutral |
| Stochastic | 70.6 | Neutral |
RCKY's weekly RSI is 69 (neutral) and its Stochastic is 71 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
RCKY PE vs Consumer Cyclical Sector
| Metric | RCKY | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 18x | 37% below |
| PE % | 28 | 47 | 19 pts below |
RCKY has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
RCKY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.7 | 8.4% above |
| 20 week MA | $45.7 | 13% above |
| 50 week MA | $40.2 | 29% above |
| 100 week MA | $32.0 | 62% above |
| 200 week MA | $29.0 | 79% above |
RCKY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
RCKY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $28.7 | 0% |
| 2021 | $28.7 | $38.6 | +35% |
| 2022 | $38.6 | $24.0 | -38% |
| 2023 | $24.0 | $30.2 | +26% |
| 2024 | $30.2 | $22.5 | -25% |
| 2025 | $22.5 | $30.0 | +33% |
| 2026 YTD | $30.0 | $51.7 | +72% |
RCKY has the edge over AMZN on returns for 2026, with the stronger performance.